CARDIOSPEC™ Non-invasive Extracorporeal Myocardial Shockwave Therapy.

Indicated for patients suffering from refractory angina pectoris due to inoperable coronary artery disease with demonstrated reversible ischemia.

Extracorporeal Shockwave Myocardial Revascularization (ESMR™) stimulates formation of collateral blood vessels (angiogenesis) in ischemic myocardium, enhancing myocardial perfusion.

Applying triggered, echo-guided, low-energy focused shock waves, this novel therapy offers a non-invasive treatment solution via short term, repeatable treatment with no side effects.

ESMR™ technology has proven to be safe in more than 60 medical centers worldwide.

Manufactured in Israel.

NOTE: This medical device can only be supplied and used by a qualified healthcare practitioner.

NOTE: Always follow 'Instructions For Use' for indications, warnings, precautions & device preparation.